Senti Biosciences Stock Market Value
| SNTI Stock | USD 2.17 0.05 2.36% |
| Symbol | Senti |
Senti Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.59) | Revenue Per Share 0.075 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (1.11) |
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Senti Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Senti Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Senti Biosciences.
| 12/01/2023 |
| 11/25/2024 |
If you would invest 0.00 in Senti Biosciences on December 1, 2023 and sell it all today you would earn a total of 0.00 from holding Senti Biosciences or generate 0.0% return on investment in Senti Biosciences over 360 days. Senti Biosciences is related to or competes with Cadrenal Therapeutics,, Foghorn Therapeutics, Quoin Pharmaceuticals, Cingulate, Lipella Pharmaceuticals, Fennec Pharmaceuticals, and Monopar Therapeutics. Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene ther... More
Senti Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Senti Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Senti Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 29.34 | |||
| Value At Risk | (7.36) | |||
| Potential Upside | 7.35 |
Senti Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Senti Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Senti Biosciences' standard deviation. In reality, there are many statistical measures that can use Senti Biosciences historical prices to predict the future Senti Biosciences' volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (0.96) | |||
| Treynor Ratio | (0.60) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Senti Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Senti Biosciences Backtested Returns
Senti Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0545, which indicates the firm had a -0.0545% return per unit of risk over the last 3 months. Senti Biosciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Senti Biosciences' Variance of 22.08, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,290) to confirm the risk estimate we provide. The entity has a beta of 0.36, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Senti Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Senti Biosciences is expected to be smaller as well. At this point, Senti Biosciences has a negative expected return of -0.25%. Please make sure to validate Senti Biosciences' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Senti Biosciences performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.51 |
Modest predictability
Senti Biosciences has modest predictability. Overlapping area represents the amount of predictability between Senti Biosciences time series from 1st of December 2023 to 29th of May 2024 and 29th of May 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Senti Biosciences price movement. The serial correlation of 0.51 indicates that about 51.0% of current Senti Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.21 |
Senti Biosciences lagged returns against current returns
Autocorrelation, which is Senti Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Senti Biosciences' stock expected returns. We can calculate the autocorrelation of Senti Biosciences returns to help us make a trade decision. For example, suppose you find that Senti Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Senti Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Senti Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Senti Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Senti Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Senti Biosciences Lagged Returns
When evaluating Senti Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Senti Biosciences stock have on its future price. Senti Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Senti Biosciences autocorrelation shows the relationship between Senti Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Senti Biosciences.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Senti Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Senti Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Senti Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Senti Biosciences Stock:Check out Senti Biosciences Correlation, Senti Biosciences Volatility and Senti Biosciences Alpha and Beta module to complement your research on Senti Biosciences. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Senti Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.